Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Tyra Biosciences, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 45 | 46 | +1 |
| Shares | 35.2M | 36.1M | +959.6K (+2.7%) |
| Value | $494.2M | $386.6M | −$107.5M (−21.8%) |
New holders (7)
Institutions that held Tyra Biosciences, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 1,327,665 | $14.2M | 1.21% |
| Sio Capital Management, LLC | 111,033 | $1.19M | 0.48% |
| Rhumbline Advisers | 11,726 | $125.0K | 0.00% |
| New York State Common Retirement Fund | 10,517 | $113.0K | 0.00% |
| Barclays PLC | 1,915 | $20.0K | 0.00% |
| Amalgamated Bank | 1,771 | $19.0K | 0.00% |
| Amalgamated Financial Corp. | 1,771 | $19.0K | 0.00% |
Sold out (6)
Institutions that held Tyra Biosciences, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Frazier Management LLC | 1,250,000 | $17.6M |
| Millennium Management LLC | 109,523 | $1.54M |
| HRT Financial LP | 17,999 | $253.0K |
| Old Well Partners, LLC | 10,500 | $148.0K |
| STRS Ohio | 2,800 | $39.0K |
| Northwestern Mutual Wealth Management Co | 300 | $4.00K |